Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 123.083M	--
--	2024/Q4	-- / 124.300M	--
Oct 29, 2024	2024/Q3	115.910M / 112.254M	--
Jul 30, 2024	2024/Q2	116.269M / 116.184M	--
May 1, 2024	2024/Q1	108.851M / 106.902M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 123.083M--

--2024/Q4-- / 124.300M--

Oct 29, 20242024/Q3115.910M / 112.254M--

Jul 30, 20242024/Q2116.269M / 116.184M--

May 1, 20242024/Q1108.851M / 106.902M--

Unlock Free Earnings Estimates

Open Account

AtriCure Earnings Reports

AtriCure | 8-K: AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2024, Provides Financial Outlook for 2025, and Announces Upcoming Analyst & Investor Day

Jan 13 08:02 ET

AtriCure | 10-Q: Q3 2024 Earnings Report

Oct 30, 2024 11:52 ET

AtriCure | 8-K: AtriCure Reports Third Quarter 2024 Financial Results

Oct 29, 2024 16:05 ET

AtriCure | 10-Q: Q2 2024 Earnings Report

Jul 31, 2024 11:46 ET

Trending US Stocks

Symbol Mini Chart % Chg

Hutchmed (China)

HCM

+6.61%